BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 108127
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.108127
Table 3 General post operative outcomes, median (IQR)/n (%)
Variable
Oral Impact (n = 28)
Nutren Optimum (n = 30)
P value
Initiation of clear fluid (days)1.0 (0.3)1.0 (0.8)0.783
Initiation of nourishing fluid (days)2.0 (1.0)2.0 (1.0)0.877
Initiation of soft diet (days)4.0 (1.0)4.0 (2.0)0.274
Return to normal diet (days)4.0 (1.0)5.0 (1.8)0.189
Flatus (days)2.0 (1.0)2.0 (1.0)0.640
Bowel output (days)3.0 (0.0)3.0 (1.0)0.200
Unknown11
C-reactive protein (day 3 post surgery), mean ± SD78.2 ± 57.7102.1 ± 56.10.116
Duration of antibiotic (days)4.0 (3.3)5.0 (2.8)0.100
Indication of antibiotic0.192
Prophylactic16 (57.1)12 (40.0)
Treatment12 (42.9)18 (60.0)
ICU stay (days)11 (39.3)15 (50.0)0.412
Total length of hospital stays (days)6.0 (2.3)7.0 (3.0)0.353


Write to the Help Desk